Active Ingredient(s):Trimethadione FDA Approved: * January 25, 1946 Pharm Company: *ABBOTT Category:Anticonvulsant
Trimethadione (Tridione) is an oxazolidinedione anticonvulsant. It is most commonly used to treat epileptic conditions that are resistant to other treatments.
It is primarily effective in treating absence seizures, but can also be used in refractory temporal lobe epilepsy. It is usually administered 3 or 4 times daily, with the total daily dose ranging from 900 mg to 2.4 g. Treatment is most effective when the concentration of its active metabolite, dimethadione, is above 700 µg/mL. Seve...
* May have multiple approval dates, manufacturers, or labelers.